{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018684","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2025-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.220541+00:00","generated_at":"2026-05-17T03:11:51.555048+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Palisade Bio shareholders approve reverse stock split of 1:5 to 1:50, board to decide ratio","bullets":["Three directors re-elected: J.D. Finley (647,086 votes for), Donald Williams (641,789), Emil Chuang (659,895); each had 2,849,169 broker non-votes.","Baker Tilly ratified as auditor for FY2025 with 3,348,348 votes for, 108,424 against.","Reverse stock split amendment approved 2,353,265 for to 1,122,616 against; board may set ratio 1:5 to 1:50, implement by Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018684","json":"https://secwatch.observer/filing/0001493152-25-018684.json","markdown":"https://secwatch.observer/filing/0001493152-25-018684.md","text":"https://secwatch.observer/filing/0001493152-25-018684.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/0001493152-25-018684-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:11:51.555048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}